Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse Alt

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|December 21, 2013
δ-Thiolactones as prodrugs of thiol-based glutamate carboxypeptidase II (GCPII) inhibitorsDana V Ferraris, Pavel Majer, Chiyou Ni, et al.
ACS Medicinal Chemistry Letters|December 18, 2012
Synthesis and SAR of 1-hydroxy-1H-benzo[d]imidazol-2(3H)-ones as Inhibitors of D-Amino Acid OxidaseJames F Berry, Dana V Ferraris, Bridget Duvall, et al.
Acta Pharmacologica Sinica|May 12, 2025
Translin deletion impairs cocaine-induced locomotor sensitization and RGS8 expression in the nucleus accumbensXiu-Ping Fu, Ren-Kun Wu, Aparna P Shah, et al.
Pharmaceutics|October 27, 2022
D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase IISadakatali S Gori, Ajit G Thomas, Arindom Pal, et al.
Journal of Medicinal Chemistry|August 5, 2022
Discovery of Orally Bioavailable and Brain-Penetrable Prodrugs of the Potent nSMase2 Inhibitor DPTIPArindom Pal, Sadakatali Gori, Seung-Wan Yoo, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 7, 2025
Targeting NAAG metabolism restores cognition and synaptic integrity in EcoHIV-infected miceYuxin Zheng, Meixiang Huang, R Michael Maragakis, et al.
Biochemical Pharmacology|October 22, 2021
Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injuryCarolyn Tallon, Silvia Picciolini, Seung-Wan Yoo, et al.
Translational Oncology|July 25, 2019
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastomaAllison R Hanaford, Jesse Alt, Rana Rais, et al.
Journal of Medicinal Chemistry|February 14, 2014
Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminaseDana Ferraris, Bridget Duvall, Greg Delahanty, et al.
Cancers|March 10, 2022
Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine PathwaysKhoa Pham, Allison R Hanaford, Brad A Poore, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|December 21, 2013
δ-Thiolactones as prodrugs of thiol-based glutamate carboxypeptidase II (GCPII) inhibitorsDana V Ferraris, Pavel Majer, Chiyou Ni, et al.
ACS Medicinal Chemistry Letters|December 18, 2012
Synthesis and SAR of 1-hydroxy-1H-benzo[d]imidazol-2(3H)-ones as Inhibitors of D-Amino Acid OxidaseJames F Berry, Dana V Ferraris, Bridget Duvall, et al.
Acta Pharmacologica Sinica|May 12, 2025
Translin deletion impairs cocaine-induced locomotor sensitization and RGS8 expression in the nucleus accumbensXiu-Ping Fu, Ren-Kun Wu, Aparna P Shah, et al.
Pharmaceutics|October 27, 2022
D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase IISadakatali S Gori, Ajit G Thomas, Arindom Pal, et al.
Journal of Medicinal Chemistry|August 5, 2022
Discovery of Orally Bioavailable and Brain-Penetrable Prodrugs of the Potent nSMase2 Inhibitor DPTIPArindom Pal, Sadakatali Gori, Seung-Wan Yoo, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 7, 2025
Targeting NAAG metabolism restores cognition and synaptic integrity in EcoHIV-infected miceYuxin Zheng, Meixiang Huang, R Michael Maragakis, et al.
Biochemical Pharmacology|October 22, 2021
Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injuryCarolyn Tallon, Silvia Picciolini, Seung-Wan Yoo, et al.
Translational Oncology|July 25, 2019
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastomaAllison R Hanaford, Jesse Alt, Rana Rais, et al.
Journal of Medicinal Chemistry|February 14, 2014
Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminaseDana Ferraris, Bridget Duvall, Greg Delahanty, et al.
Cancers|March 10, 2022
Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine PathwaysKhoa Pham, Allison R Hanaford, Brad A Poore, et al.
Pageof 8